NCT02145299 - The Lumen Study: Comparing Devices for Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions

Symptomatic Femoro-popliteal Chronic Total Occlusion

Interventions

DEVICE

TruePath CTO Device

"The TruePath CTO Device is composed of a 0.018 guidewire and a motor housing with a connector cable along with a sterile, disposable battery-powered Control Unit for manipulation of the device during operation. The TruePath CTO Device is indicated to facilitate the intra-luminal placement of conventional guidewires beyond peripheral artery chronic total occlusions."

DEVICE

CROSSER CTO Device

Trial Locations (1)

06510

Yale Cardiovascular Research Group, New Haven